Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients

Other users also viewed these articles

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients C. Gabara, B. Solarat, P. Castro, S. Fernández, J.R. Badia, D. Toapanta, S. Schulman, J.C. Reverter, A. Soriano, J. Moisés, J. Aibar

10.1016/j.medine.2021.07.006

Coagulation disorders in patients with chronic liver disease: A narrative review Daida García Rodríguez, Gabriela Alexandra Narváez Chávez, Sergio Tomás Rodríguez Ramos, Ángel Orera Pérez, Jesús Emilio Barrueco-Francioni, Pedro Merino García

10.1016/j.medine.2025.502216

Outcomes of renal replacement therapy in the critically ill with COVID-19 E. Burke, E. Haber, C.W. Pike, R. Sonti

10.1016/j.medine.2021.02.006